Regional Report - Gundersen Health System

More documents

Recommendations

Info

Minimally invasive surgeries – continued surgery allow us to perform more minimally invasive procedures, but our patients will benefit with a shorter hospital stay and quicker return to normal daily activities,” adds urologist Chris Hofland, MD, who also performs procedures using the da Vinci. Currently, the Gundersen Lutheran physicians show at right are using the da Vinci Surgical System. If you have a patient who might benefit from this technology, contact one of these physicians via MedLink. Dana Benden, MD Specialty: Obstetrics & Gynecology MD Degree: University of Wisconsin Medical College, Madison Residency: Illinois Masonic Medical Center, Chicago Chris Hofland, MD Specialty: Urology MD Degree: University of Wisconsin – Madison Internship: William Beaumont Army Medical Center, El Paso, Texas Residency: Tripler Regional Medical Center, Honolulu, Hawaii Richard Renwick, MD Specialty: Obstetrics & Gynecology MD Degree: University of Wisconsin Medical School, Madison Internship and Residency: University of Oregon Health Sciences, Portland, Ore. Surgeons operate the machine while seated at a console viewing a 3-D image of the surgical field. The surgeon’s fingers grasp the master controls below the display. The surgeon’s hand, wrist and finger movements are translated into precise, real-time movements of the robotic arms positioned inside the patient. The system’s tremor reduction and motion control deliver precise control far beyond the capabilities of the human hand. Marvin Van Every, MD Specialty: Urology MD Degree: University of Southern California, Los Angeles Internship: David Grant USAF Medical Center, Travis AFB, Calif. Residency: Wilford Hall USAF Medical Center, San Antonio, Texas Federal funding for health information technology Patients throughout the Tri-state Region will benefit from advancements in health information technology (IT) that will be made possible through federal funding. Wisconsin senator Herb Kohl visited Gundersen Lutheran to announce $300,000 in federal funding for health IT programs. “Health information technology is a critical component to providing healthcare throughout the Tri-state Region, helping to prevent medical errors and reduce healthcare costs,” says Gundersen Lutheran chief information officer Deb Rislow. Sen. Kohl has been a strong supporter of the health IT work at Gundersen Lutheran. In fact, last year he secured $189,000 in News Brief federal funding so Gundersen Lutheran could establish digital connectivity between healthcare facilities in the Tri-state Region. With 50 percent of patients referred from facilities outside of La Crosse County, the ability to access up-to-date medical information is key to coordinating care. In the future, Gundersen Lutheran hopes to expand its partnerships and interconnectivity with all regional healthcare facilities. “Gundersen Lutheran and non-Gundersen Lutheran partners throughout the region have created a healthcare environment that progressively uses health information technology. That health IT network promotes efficient, safe and coordinated medical care in a rural environment,” Rislow says. MedLink (800) 336–5465 2 In La Crosse 775–5465
The CCBD earns special funding for clinical trials Gundersen Lutheran’s Center for Cancer & Blood Disorders (CCBD) was recently identified as one of the top 25 highest accruing sites in the Clinical Trials Working Group by the Eastern Cooperative Oncology Group (ECOG). In addition to being recognized for past performance by ECOG, the CCBD also received special funding of $16,900 to support future clinical trials. This monetary award will be used to improve clinical cancer research programs that benefit both local patients and their counterparts in other cooperative study groups throughout the nation. Principal investigator for the CCBD, Alcee Jumonville, MD, Medical Oncology, says, “This special funding will continue to assure the activity of our research office. We are grateful to ECOG for this designation and feel the commitment of the clinicians and the research staff for this level of performance remains strong for the foreseeable future.” Gundersen Lutheran has affiliations with ECOG, in addition to numerous other regional and national research groups. “At any given time, we have more than 130 pediatric and adult cancer clinical trials going on at the Center for Cancer & Blood Disorders. With support from Gundersen Lutheran Medical Foundation, we are able to offer these cancer clinical trials through participation in regional and national oncology research groups. This gives our patients access to investigational treatments available at major cancer centers throughout the United States,” says Ronald Go, MD, Hematology, one of Gundersen Lutheran’s cancer researchers. The success of the research team, led by Dr. Go and Dr. Jumonville, would not be possible without the significant support by Gundersen Lutheran Medical Foundation, which helps cover the costs of performing clinical trials. Gundersen Lutheran participates in the following regional and national research groups: • Eastern Cooperative Oncology Group (ECOG) • Children’s Oncology Group (COG) • National Surgical Adjuvant Breast and Bowel Project (NSABP) • Radiation Therapy Oncology Group (RTOG) • Children’s Oncology Group of the Upper Midwest (COGUM) • Wisconsin Oncology Network (linked with University of Wisconsin–Madison) • Gynecologic Oncology Group (GOG) • National Hemophilia Foundation-Region V West • American College of Surgeons Oncology Group (ACOSOG) • Clinical Trials Support Unit (CTSU), a service of the National Cancer Institute Alcee Jumoville, MD Specialty: Hemoatology-Oncology MD Degree: University of New Mexico, Albuquerque Internship and Residency: Gundersen Lutheran Medical Foundation, La Crosse, Wis. Fellowship: Dartmouth-Hitchcock Medical Center, Lebanon, N.H. Ronal Go, MD Specialty: Hemoatology-Oncology MD Degree: University of Santo Tomas, Manila, Philippines Internship and Residency: Baylor Collee of Medicine, Houston, Texas Fellowship: Mayo Clinic, Rochester, Minn. News Brief Gundersen Lutheran takes cancer research to a new level Gundersen Lutheran has been a long-time leader in cancer research in the Tri-state Region. Now, they will be able to take research one step further, thanks to a very generous donation. Recently, Gundersen Lutheran Medical Foundation announced the creation of the Dr. Jon and Betty Kabara Cancer Research Institute at Gundersen Lutheran. “Dr. Jon and his wife Betty have lost family members due to cancer. It is their wish that this gift be directed toward the study of nutrition and lipids in cancer biology in the hopes of uncovering new pathways to its cause and cure,” says Phil Schumacher, The Foundation executive director. Dr. Kabara has dedicated his entire adult life to science and research. He has been a professor at Michigan State University for 20 years, and an investigator in biochemistry for the past 50 years. “We were surprised to learn the Kabaras were making this generous gift to Gundersen Lutheran because they are not from the area and do not receive their care here. It’s a testament to our organization that they recognized the outstanding work that’s being done by our medical staff and researchers, and entrusted us with a cancer research institute that bears their name,” comments Mark V. Connelly, MD, FACS, chairman, Gundersen Lutheran Medical Foundation. MedLink (800) 336–5465 3 In La Crosse 775–5465
Page 1: Fall 2008 Volume 23 - No. 3 Regiona
Page 5 and 6: Vascular Institute sees success wit
Page 7 and 8: New Practices Pulmonary, Sleep Medi
Page 9 and 10: Gastric bypass surgery reduces use

Regional Report - Gundersen Health System

Create successful ePaper yourself

Delete template?

Save as template?